elevidys - Search News

News

Sarepta, Elevidys and gene therapy

Sarepta resumes shipping of gene therapy Elevidys to patients who can walk

Sarepta Therapeutics said on Monday it will resume shipping of its muscular disorder gene therapy to patients who can walk, sending the company's shares 59% higher in extended trading. The announcement came immediately after the U.

MIT Technology Review · 3d

The deadly saga of the controversial gene therapy Elevidys

· 8h · on MSN

FDA Says Sarepta Can Resume Gene Therapy in Some Patients

Sarepta Therapeutics to Lift Pause on Shipments of Duchenne Treatment Elevidys

Sarepta Therapeutics said the Food and Drug Administration informed the company it can lift a voluntary pause on shipments of Elevidys for ambulatory patients with Duchenne. The company said Monday ...

5don MSN

Roche pauses shipments of Elevidys gene therapy outside US

Roche Holding AG said on Tuesday it has paused shipments of muscular disorder gene therapy Elevidys in some countries outside ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

Sarepta, Elevidys and gene therapy

Sarepta Therapeutics to Lift Pause on Shipments of Duchenne Treatment Elevidys

Roche pauses shipments of Elevidys gene therapy outside US

Trending now